ADOCIA Announces Second Financial Results for the Second Quarter 2021

0
9
ADOCIA Announces Second Financial Results for the Second Quarter 2021

Revenue Detail for the Second Quarter of 2021

 

 

06/30/2021
(3 months)

Story Highlights


  • Adocia (Euronext Paris: FR0011184241 – ADOC) (Paris:ADOC), a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases with innovative formulations of proteins and peptides, announced today its second quarter revenue and net cash position for the period ending on June 30, 2021.


  • In (€) thousands, IFRS standards (unaudited)

06/30/2020
(3 months)

 

06/30/2021
(6 months)

 

06/30/2020
(6 months)

Licensing revenues

 

112

 

227

68